A detailed history of Virginia Retirement Systems Et Al transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 25,300 shares of HRMY stock, worth $883,222. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,300
Previous 22,200 13.96%
Holding current value
$883,222
Previous $781,000 6.15%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$31.89 - $39.03 $98,859 - $120,993
3,100 Added 13.96%
25,300 $829,000
Q2 2023

Aug 22, 2023

BUY
$30.5 - $37.4 $350,750 - $430,100
11,500 Added 107.48%
22,200 $781,000
Q1 2023

Jul 11, 2023

BUY
$30.8 - $53.92 $154,000 - $269,600
5,000 Added 87.72%
10,700 $349,000
Q4 2022

May 17, 2023

BUY
$45.4 - $60.91 $258,780 - $347,187
5,700 New
5,700 $314 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.07B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.